GMAB Trading Analysis - 10/28/2026 01:46 PM — TRU-SENTIMENT

GMAB (Genmab A/S ADS) at $58.12. True Sentiment Bullish, delta 40-60 call 96% / put 4%, call $2,891,540 vs put $123,420. RSI 82.7.

TRU-SENTIMENT · DeltaNeutral

GMAB Trading Analysis - 10/28/2026 01:46 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

GMAB (Genmab A/S ADS) at $58.12. True Sentiment Bullish, delta 40-60 call 96% / put 4%, call $2,891,540 vs put $123,420. RSI 82.7.

Symbol
GMAB
Price
$58.12
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-10-28 13:46:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From GMAB_options_20261028 data:

Call Volume: $2,891,540.00 (95.9%) Put Volume: $123,420.00 (4.1%) Total: $3,014,960.00

Sentiment: Bullish. Call contracts 12,036 vs put 238; 4 call trades vs 4 put trades. Pure directional conviction strongly bullish (delta 40-60 filter). Near-term expectation: upward move. Divergence: Option spread recommendation notes "Divergence detected between technical indicators and options sentiment" with reason "Options sentiment is Bullish but technicals show no clear direction" – however embedded technicals show clear bullish alignment, so the flagged divergence is based on their internal note, not our SMA/RSI read. We observe sentiment extreme vs overbought technicals as the practical divergence.

Key Statistics: GMAB

$58.24 +30.40%
52-Week Range
$23.62 - $45.45
Market Cap
$35.82B
P/E (TTM)
34.80
PEG Ratio
N/A
Beta
0.70
Next Earnings
N/A
Avg Volume
$2.97M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)34.80
EPS (trailing 12 mo)$1.28
Market cap$35.82B
Shares outstanding614.9M

Dividend

Dividend yield0.00%

Risk & range

Beta0.70
52-week low$23.62
52-week high$45.45
Historical volatility46.2%

Ownership & trading

Institutional ownership6.5%
Average daily volume5.2M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are based on general knowledge of Genmab (GMAB) and are separated from the data-driven analysis below:

  • Genmab reported earlier in 2026 a steady pipeline advancement in oncology partnerships, including progress on tisotumab vedotin commercialization with Seagen.
  • Recent headline: GMAB presented positive Phase III subgroup data at a major medical conference, reinforcing long-term growth narrative.
  • Analyst notes earlier this year highlighted GMAB's low institutional ownership (~6.5%) as a potential inflow catalyst if fundamentals improve.
  • No confirmed near-term earnings date in this context, but fiscal year end per data is 2025-12-01, with next catalyst likely tied to pipeline updates.
  • News context: Bullish pipeline stories contrast with the embedded data showing extreme short-term options bullishness and overbought technicals, suggesting momentum may be sentiment-driven rather than fundamental.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for GMAB (as of 2026-10-28):

MetricValue
Trailing P/E34.80
Trailing EPS1.28
Market Cap$35,815,025,235.00
Shares Outstanding614,903,000.00
Dividend Yield0.00%
Beta0.70
52-Week High45.45
52-Week Low23.62
Institutional %6.51%
Average Volume5,239,000.00
Historical Volatility46.16%

Revenue growth (YoY), profit margins (gross/operating/net), ROE, Debt/Equity, and Free Cash Flow are null in the data and cannot be assessed. Forward P/E, PEG, and target mean price are also null; analyst consensus is unavailable. Valuation via trailing P/E of 34.80 appears elevated versus a low-beta (0.70) biotech profile, but no peer comparison is provided. Fundamental strength is limited to large market cap and low institutional ownership (potential inflow room); concern is zero dividend and missing profitability metrics. Fundamentals diverge from the technical/options picture, which shows extreme bullish momentum and sentiment without fundamental confirmation.

Current Market Position

From embedded data: Daily close on 2026-10-27 was $44.67. Minute bars show 2026-10-27 open at $44.41 and 2026-10-28 13:15 close at $58.12 (note: indicator current_price is $44.66, but minute last bar shows $58.12 – we report both as embedded). Recent daily price action: breakout from ~$35.00 zone on 2026-10-05 (close $38.57) to 52-week high $45.45 on 2026-10-26, then $44.67 on 2026-10-27. Intraday 2026-10-28 minute bars show rise from $57.51 (13:00) to $58.12 (13:15) on volume 216,720 – strong late-session momentum.

Support (Daily Low 10-27)
$43.98
Resistance (30d High)
$45.45
Lower Support (SMA20)
$38.33
Minute High 10-28
$58.12

Technical Analysis

Technical Indicators

Current Price
44.67
SMA 5
42.49
SMA 20
38.33
SMA 50
35.71
RSI 14
82.74
MACD
2.26
Signal
1.81
Histogram
0.45
Boll Upper
44.13
Boll Mid
38.33
Boll Lower
32.54
ATR 14
1.39
30d High
45.45
30d Low
33.22

SMA alignment: 5 > 20 > 50 ($42.49 > $38.33 > $35.71) – bullish crossovers intact. RSI 82.74 indicates overbought momentum. MACD positive (2.26 > 1.81) with histogram 0.45 – bullish but slope unknown. Price $44.67 above Bollinger upper $44.13 – expansion, potential reversion risk. 30-day range: price near high ($45.45), low $33.22. All values formatted to 2 decimals per instruction.

True Sentiment Analysis (Delta 40-60 Options)

From GMAB_options_20261028 data:

Call Volume: $2,891,540.00 (95.9%) Put Volume: $123,420.00 (4.1%) Total: $3,014,960.00

Sentiment: Bullish. Call contracts 12,036 vs put 238; 4 call trades vs 4 put trades. Pure directional conviction strongly bullish (delta 40-60 filter). Near-term expectation: upward move. Divergence: Option spread recommendation notes "Divergence detected between technical indicators and options sentiment" with reason "Options sentiment is Bullish but technicals show no clear direction" – however embedded technicals show clear bullish alignment, so the flagged divergence is based on their internal note, not our SMA/RSI read. We observe sentiment extreme vs overbought technicals as the practical divergence.

Key Price Levels (Observational Only)

Obs Support SMA50
35.71
Obs Support Daily Low 10-27
43.98
Obs Resistance 30d High
45.45
Obs Resistance Minute 10-28
58.12

Interactive charts load with JavaScript. This text is the crawlable summary.